Histamine H1 receptors in schizophrenic patients measured by positron emission tomography

European Neuropsychopharmacology

Volumn 15, Issue 2, 2005, Pages 185-191

  Iwabuchi, Kentaro ^a   Ito, Chihiro ^a   Tashiro, Manabu ^a   Kato, Motohisa ^a   Kano, Michiko ^a   Itoh, Masatoshi ^b   Iwata, Ren ^b   Matsuoka, Hiroo ^a   Sato, Mitsumoto ^c   Yanai, Kazuhiko ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU FUKUSHI UNIVERSITY   (Japan)

Author keywords

H1 receptors; Histamine; Histamine neurons; Positron emission tomography; Receptor imaging; Schizophrenia; 11C doxepin

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BIPERIDEN; BROTIZOLAM; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOXAZOLAM; DOXEPIN; DOXEPIN C 11; FLUNITRAZEPAM; HALOPERIDOL; HISTAMINE H1 RECEPTOR; NEUROLEPTIC AGENT; QUAZEPAM; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; AKATHISIA; ANXIETY; ARTICLE; BRAIN; CINGULATE GYRUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HYPOTHESIS; IN VIVO STUDY; INSOMNIA; MALE; MEASUREMENT; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; SCHIZOPHRENIA; STATISTICAL PARAMETERS; ANALYSIS OF VARIANCE; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN BINDING;

ADULT; ANALYSIS OF VARIANCE; BRAIN; DOXEPIN; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTORS, HISTAMINE H1; SCHIZOPHRENIA;

EID: 19944430541     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2004.10.001     Document Type: Article

References (30)

1. R.E. Brown, D.R. Stevens, and H.L. Haas The physiology of brain histamine Prog. Neurobiol. 63 2001 637 672
2. R.E. Carson, P. Herscovitch, and M.E. Daube-Witherspoon Quantitative Functional Brain Imaging with Positron Emission Tomography 1998 Academic Press San Diego, CA
3. H. Dai, H. Okuda, K. Iwabuchi, E. Sakurai, Z. Chen, M. Kato, K. Iinuma, and K. Yanai Social isolation stress significantly enhanced the disruption of prepulse inhibition in mice repeatedly treated with methamphetamine Ann. N. Y. Acad. Sci. 1025 2004 257 266
4. M. Endou, K. Yanai, E. Sakurai, S. Fukudo, M. Hongo, and T. Watanabe Food-deprived activity stress decreased the activity of the histaminergic neuron system in rats Brain Res. 891 2001 32 41
5. K.J. Friston Commentary and opinion: II. Statistical parametric mapping: ontology and current issues J. Cereb. Blood Flow Metab. 15 1995 361 370
6. T. Fujiwara, S. Watanuki, S. Yamamoto, M. Miyake, S. Seo, M. Itoh, K. Ishii, H. Orihara, H. Fukuda, T. Satoh, K. Kitamura, K. Tanaka, and S. Takahashi Performance evaluation of a large axial field-of-view PET scanner: SET-2400W Ann. Nucl. Med. 11 1997 307 313
7. H. Haas, and P. Panula The role of histamine and the tuberomamillary nucleus in the nervous system Nat. Rev., Neurosci. 4 2003 121 130
8. 1 receptors in patients with Alzheimer's disease assessed by positron emission tomography Neuroscience 99 2000 721 729
9. S.J. Hill, C.R. Ganellin, H. Timmerman, J.C. Schwartz, N.P. Shankley, J.M. Young, W. Schunack, R. Levi, and H.L. Haas International Union of Pharmacology: XIII. Classification of histamine receptors Pharmacol. Rev. 49 1997 253 278
10. 1 receptors Proc. Natl. Acad. Sci. U. S. A. 93 1996 13316 13320
11. C. Ito, K. Onodera, T. Watanabe, and M. Sato Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats Psychopharmacology (Berl.) 130 1997 362 367
12. 1 receptors in human brain labelled with [3H] doxepin Brain Res. 304 1984 1 7
13. J. Logan, J.S. Fowler, N.D. Volkow, A.P. Wolf, S.L. Dewey, D.J. Schlyer, R.R. MacGregor, R. Hitzemann, B. Bendriem, and S.J. Gatley Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects J. Cereb. Blood Flow Metab. 10 1990 740 747
14. D. Mancama, M.J. Arranz, J. Munro, S. Osborne, A. Makoff, D. Collier, and R. Kerwin Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response Neurosci. Lett. 333 2002 207 211
15. S. Morisset, C. Pilon, J. Tardivel-Lacombe, D. Weinstein, W. Rostene, C. Betancur, P. Sokoloff, J.C. Schwartz, and J.M. Arrang Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor J. Pharmacol. Exp. Ther. 300 2002 621 628
16. 1 receptors in the frontal cortex of brains from patients with chronic schizophrenia Biol. Psychiatry 30 1991 349 356
17. N. Okamura, K. Yanai, M. Higuchi, J. Sakai, R. Iwata, T. Ido, H. Sasaki, T. Watanabe, and M. Itoh Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine Br. J. Pharmacol. 129 2000 115 123
18. C. Pillot, J. Ortiz, A. Heron, S. Ridray, J.C. Schwartz, and J.M. Arrang Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat J. Neurosci. 22 2002 7272 7280
19. G.D. Prell, and J.P. Green Histamine as a neuroregulator Annu. Rev. Neurosci. 9 1986 209 254
20. G.D. Prell, J.P. Green, C.A. Kaufmann, J.K. Khandelwal, A.M. Morrishow, D.G. Kirch, M. Linnoila, and R.J. Wyatt Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms Schizophr. Res. 14 1995 93 104
21. F.P. Rauscher, H.A. Nasrallah, and R.J. Wyatt Cutaneous histamine response in schizophrenia J. Clin. Psychiatry 41 1980 44 51
22. E. Richelson, and T. Souder Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds Life Sci. 68 2000 29 39
23. J.C. Schwartz, J.M. Arrang, M. Garbarg, H. Pollard, and M. Ruat Histaminergic transmission in the mammalian brain Physiol. Rev. 71 1991 1 51
24. 1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine Br. J. Clin. Pharmacol. 52 2001 501 509
25. J. Talairach, and P. Tournoux Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: an Approach to Cerebral Imaging 1988 G. Thieme Medical Publishers Stuttgart
26. 11C-doxepin positron emission tomography J. Clin. Pharmacol. 44 2004 890 900
27. H. Wada, N. Inagaki, A. Yamatodani, and T. Watanabe Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci. 14 1991 415 418
28. T. Watanabe, and K. Yanai Studies on functional roles of the histaminergic neuron system by using pharmacological agents, knockout mice and positron emission tomography Tohoku J. Exp. Med. 195 2001 197 217
29. L. Yan, C.L. Szumlanski, S.R. Rice, J.L. Sobell, H.M. Lachman, and R.M. Weinshilboum Histamine N-methyltransferase functional polymorphism: lack of association with schizophrenia Am. J. Med. Genet. 96 2000 404 406
30. 1 antagonists measured by positron emission tomography Br. J. Pharmacol. 116 1995 1649 1655